Guardant Health, Inc. (GH)

NasdaqGS • Currently up 0.90 (+0.56%) in today's trading session

3 members of Congress have disclosed 26 trades in Guardant Health, Inc. (GH) via STOCK Act filings. The most recent disclosure was filed by Sheldon Whitehouse on 21 November 2025. The most active traders have been Donald S. Beyer (23), Sheldon Whitehouse (2), and Donald Sternoff Beyer Jr (1). Aggregate disclosed activity totals roughly $96K in purchases and $96K in sales (midpoint estimates from bracketed disclosure amounts).

Guardant Health, Inc. is currently trading at $162.99, positioned at 78% of its 52-week range ($64.00 – $191.05).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$162.99
24h Change
+0.90 (+0.56%)
52 Week Range
$64.00–$191.05
View on NASDAQ

Guardant Health, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for GH

Select to highlight on chart
5 transactions
Compliance: 42%
Sheldon Whitehouse21 Nov 20251 Dec 2025Stock$1,001 - $15,000+62.50%
Sheldon Whitehouse21 Nov 202510 Aug 2026Stock$1,001 - $15,000+62.50%
Donald S. Beyer28 Feb 20223 Mar 2022SaleStock$1,001 - $15,000N/A
Donald S. Beyer13 Jan 20221 Feb 2022SaleStock$1,001 - $15,000N/A
Donald S. Beyer22 Dec 20211 Jan 2022SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$21.87B

Volume

1.28M

Beta

1.58

P/E Ratio

-46.70

Fundamentals

EPS

$-3.49

Div. Yield

-

Open

$160.50

Day Range

$159.00 – $166.16

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
Helmy Eltoukhy
IPO Date
2018-10-04

Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and int...

Earnings

Next Report

Q3 2026

5 Nov

EPS Est.

$-0.75

Rev. Est.

$350.8M

Days Until

21

Recent Quarters

Q2 202630 Jul
EPS$-0.90
Miss 18.1%
Q1 20267 May
EPS$-0.85
Miss 5.5%
Q4 202519 Feb
EPS$-1.00
Miss 30.4%
Q3 202529 Oct
EPS$-0.74
Beat 6.3%
Q2 202530 Jul
EPS$-0.80
Miss 8.0%
Q1 202530 Apr
EPS$-0.77
Beat 1.3%
Q4 202420 Feb
EPS$-0.90
Miss 20.0%
Q3 20246 Nov
EPS$-0.88
Miss 60.0%
Q2 20247 Aug
EPS$-0.84
Miss 13.5%
Q1 20249 May
EPS$-0.94
Miss 10.6%
Q4 202322 Feb
EPS$-1.58
Miss 83.3%
Q3 20236 Nov
EPS$-0.73
Beat 23.2%
Q2 20233 Aug
EPS$-0.67
Beat 46.4%
Q1 20239 May
EPS$-1.30
Beat 1.5%
Q4 202223 Feb
EPS$-1.36
Beat 0.7%
Q3 20223 Nov
EPS$-1.58
Miss 25.4%
Q2 20224 Aug
EPS$-2.25
Miss 80.0%
Q1 20225 May
EPS$-1.21
Beat 0.0%
Q4 202123 Feb
EPS$-0.89
Beat 22.6%
Q3 20214 Nov
EPS$-1.06
Miss 17.8%
Q2 20215 Aug
EPS$-0.96
Miss 12.9%
Q1 20216 May
EPS$-1.09
Miss 22.9%
Q4 202024 Feb
EPS$-0.94
Miss 64.9%
Q3 20205 Nov
EPS$-0.78
Miss 100.0%
Q2 20206 Aug
EPS$-0.57
Miss 50.0%
Q1 20207 May
EPS$-0.29
Beat 25.6%
Q4 201924 Feb
EPS$-0.27
Beat 12.9%
Q3 20197 Nov
EPS$-0.14
Beat 62.2%
Q2 20196 Aug
EPS$-0.13
Beat 63.9%
Q1 20199 May
EPS$-0.30
Beat 18.9%
Q4 201812 Mar
EPS$-0.30
Beat 14.3%
Q3 201819 Nov
EPS$-1.94
Miss 569.0%
Q3 20185 Oct
EPS$-0.26
Beat 78.7%
Q4 201731 Mar
EPS$-0.20
Q3 201731 Dec
EPS$-0.21
Q2 201730 Sept
EPS$-0.40
Q1 201730 Jun
EPS$-1.78
Q4 201631 Mar
EPS$-1.54

15 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVS

Novartis AG

74
$146.88+4.47 (+3.14%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

CVS

CVS Health Corporation

74
$90.39+2.84 (+3.24%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
2 politicians
View Stock

NVDA

NVIDIA Corporation

62
$221.30-7.22 (-3.16%)
Technology
2 politicians both hold this
Significant holdings value
2 politicians
View Stock

Frequently Asked Questions about GH

Which members of Congress have traded GH?
3 members of Congress have disclosed 26 trades in Guardant Health, Inc. (GH) under the STOCK Act. The most active traders are Donald S. Beyer, Sheldon Whitehouse, and Donald Sternoff Beyer Jr.
When was GH most recently disclosed by Congress?
The most recent GH disclosure was filed by Sheldon Whitehouse on 21 November 2025.
What is the total disclosed congressional trading volume for GH?
Members of Congress have disclosed approximately $96K in GH purchases and $96K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in GH?
This GH page updates as soon as new STOCK Act disclosures are filed for Guardant Health, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.